Avalon Globocare Corp.

BioCentury’s ASH21 analysis identifies 22 new targets spanning seven mechanistic categories

In the race to develop the next generation of COVID-19 vaccines, at least 22 vaccine programs are being developed with an intranasal route of administration.  Intranasal vaccines may provide

Flagship newco Tessera uses mobile genetic elements to make gene insertions